Retham Technologies

Retham Technologies is a biotech company that provides a diagnosis of heparin induced thrombocytopenia by enabling rapid HIT testing.

Health and bioDeveloper tools and cloud

Retham Technologies raised $1.5M in a Seed round announced September 15, 2026, according to linkedin.com. Investors in that round: Talents Fund, Golden Angels Investors, Milwaukee Venture Partners.

Founders and team

• AP
  Anand Padmanabhan Founder

  source: crunchbase.com

Raise history

1. September 15, 2026
   Seed · $1.5M
   TTalents Fund (lead), GGolden Angels Investors, MMilwaukee Venture Partners
   Source: linkedin.com

Investors

• GGolden Angels Investors
• MMilwaukee Venture Partners
• NNational Institutes of Health
• SSBIR Advance
• TTalents Fund

Related bio health companies

• MM-BasedOct 1, 2026
• AAyna HealthOct 1, 2026
• VVytalYou$830K · Sep 30, 2026
• LLindera USSep 29, 2026
• OOrtet$500M · Sep 29, 2026
• AAptadir Therapeutics$45M · Sep 29, 2026
• GGoerSep 29, 2026
• FFreyyaSep 29, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/retham-technologies.